The majority of KG-1 cells were CD34+, which were relatively less mature than CD34− HL-60 and PL-21 cells (Fig. 2A), suggesting that cardiac glycosides preferentially target primitive AML cells. This evidence concerns the gene CD34 and acute myeloid leukemia.